Life sciences
Our specialist life sciences team understand the complex nature of the sector.
Time-to-market and funding are the crucial factors driving innovation and successful new pharmaceutical product launches, which in turn, require laboratories, vivaria, pilot plants and manufacturing facilities. Avison Young’s specialists understand the pharmaceutical product life cycle as well as the technical complexities that can create significant budgetary and scheduling risk.
We’ve successfully addressed the risks that surround real estate decision making throughout all phases of the product life cycle and across all technical aspects of planning, designing, engineering and constructing any type of life science space.

Trend #3: Doctor’s orders
Medical office and related property sectors are seeing increased investor demand. Learn the role data is playing toward insights in our 10 trends for CRE in 2023 report.

Life Sciences key contacts


News and updates
-
News Release
The Autumn Statement and what it means for Property23 November 2023
-
News Release
Avison Young's London Office appoints Co-Managing Directors7 November 2023
-
Avison Young’s tenth annual global Day of Giving event initiates change through 7,640 hours of action and partnership with local operations5 October 2023
-
Avison Young’s tenth annual global Day of Giving event initiates change through 7,640 hours of action and partnership with local operations5 October 2023